Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin in Children With Central Precocious Puberty
NCT07710430Phase 4Recruiting
- Sponsor
- LG Chem
- Start
- Aug 2026
- Primary completion
- Aug 2029
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in central precocious puberty (CPP), sponsored by LG Chem. Started Aug 2026; status: recruiting.
02
Drugs
leuprolide
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT07710430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07710430.